International audienceOcular gene therapy approaches have been developed for a variety of different diseases. In particular, clinical gene therapy trials for RPE65 mutations, X-linked retinoschisis, and choroideremia have been conducted at different centers in recent years, showing that adeno-associated virus (AAV)-mediated gene therapy is safe, but limitations exist as to the therapeutic benefit and long-term duration of the treatment. The technique of vector delivery to retinal cells relies on subretinal injection of the vector solution, causing a transient retinal detachment. Although retinal detachments are known to cause remodeling of retinal neuronal structures as well as significant cell loss, the possible effects of this short-term ...
PURPOSE: In an earlier study we found normal adeno-associated viral vector type 2 (AAV2)-mediated GF...
This study was designed to evaluate the efficacy of subretinal injection of recombinant adeno-associ...
Background: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer ...
Ocular gene therapy approaches have been developed for a variety of different diseases. In particula...
Ocular gene therapy approaches have been developed for a variety of different diseases. In particula...
Purpose: Previous studies have demonstrated that adenoassociated virus (AAV) efficiently transduced ...
Vectors based on the adeno-associated virus (AAV) are currently the preferred tools for delivering g...
Dog models with spontaneously occurring mutations in retinal dystrophy genes are an invaluable resou...
Recombinant adeno-associated virus (rAAV) vectors are increasingly being used as tools for gene ther...
Gene therapy using adeno-associated viral vectors (AAV) for the treatment of retinal degenerations h...
BACKGROUND: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer ...
Gene transfer using adeno-associated viruses (AAVs) has been effective for treating inherited retina...
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise for th...
The viral gene delivery of optogenetic actuators to the surviving inner retina has been proposed as ...
International audienceGene transfer to the retina using recombinant adeno-associated viral (rAAV) ve...
PURPOSE: In an earlier study we found normal adeno-associated viral vector type 2 (AAV2)-mediated GF...
This study was designed to evaluate the efficacy of subretinal injection of recombinant adeno-associ...
Background: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer ...
Ocular gene therapy approaches have been developed for a variety of different diseases. In particula...
Ocular gene therapy approaches have been developed for a variety of different diseases. In particula...
Purpose: Previous studies have demonstrated that adenoassociated virus (AAV) efficiently transduced ...
Vectors based on the adeno-associated virus (AAV) are currently the preferred tools for delivering g...
Dog models with spontaneously occurring mutations in retinal dystrophy genes are an invaluable resou...
Recombinant adeno-associated virus (rAAV) vectors are increasingly being used as tools for gene ther...
Gene therapy using adeno-associated viral vectors (AAV) for the treatment of retinal degenerations h...
BACKGROUND: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer ...
Gene transfer using adeno-associated viruses (AAVs) has been effective for treating inherited retina...
Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise for th...
The viral gene delivery of optogenetic actuators to the surviving inner retina has been proposed as ...
International audienceGene transfer to the retina using recombinant adeno-associated viral (rAAV) ve...
PURPOSE: In an earlier study we found normal adeno-associated viral vector type 2 (AAV2)-mediated GF...
This study was designed to evaluate the efficacy of subretinal injection of recombinant adeno-associ...
Background: Adeno-associated virus (AAV) is well established as a vehicle for in vivo gene transfer ...